News Headline -The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the withdrawal, suspension, or cancellation of registration certificates for 101 pharmaceutical products. According to NAFDAC, a registration certificate may be withdrawn when the Market Authorisation Holder voluntarily discontinues the use of the product. Servier Pharmaceuticals Development Ltd recorded the highest number, with 25 products affected. Other companies on the list included Sanofi Aventis Nigeria Ltd, Fensyl MHP Consulting Ltd, Blooms Pharmaceutical Ltd, Novartis Nigeria Limited, AstraZeneca Nigeria Limited, GlaxoSmithKline Pharmaceutical Nigeria Ltd, Novo Nordisk Pharma, Janssen Pharmaceutical Companies, and several others with smaller entries. The majority of the affected products were in tablet form, which accounted for nearly three-quarters of the list.